Article Information
PubMed
Published By
History
- Received June 9, 2015
- Revision received October 30, 2015
- Accepted November 7, 2015
- First published December 9, 2015.
- Version of record published December 9, 2015.
Copyright & Usage
Copyright © 2015 the authors 0270-6474/15/3516213-08$15.00/0
Author Information
Author contributions
Author contributions: E.S., E.K., and H.K. designed research; E.S., K.L.T., A.B.R., and H.K. performed research; M.P.M. contributed unpublished reagents/analytic tools; E.S., E.K., and H.K. analyzed data; E.S., E.K., and H.K. wrote the paper.
↵*E.K. and H.K. contributed equally to this work.
Disclosures
- Received June 9, 2015.
- Revision received October 30, 2015.
- Accepted November 7, 2015.
This work was supported by National Institutes of Health Grants NS087112 (E.S.) and NS078718 (E.K.).
M.P.M. holds stock in Antipodean Pharmaceuticals, which is commercializing MitoQ as a pharmaceutical. The authors declare no other competing financial interests.
- Correspondence should be addressed to either of the following: Dr. Eric Klann, Center for Neural Science, New York University, 4 Washington Place, Room 809, New York, NY 10003, eklann{at}cns.nyu.edu; or Dr. Hanoch Kaphzan, Laboratory for Neurobiology of Psychiatric Disorders, Sagol Department of Neurobiology, University of Haifa, Mt. Carmel, Haifa 3498838, Israel, hkaphzan{at}univ.haifa.ac.il
Online Impact